muscle weakness_Tg(ACTA1-PABPN1*A17)1Drub/0

http://metadb.riken.jp/0000747IFVBNTgACTA1PABPN1A171Drub0TgACTA1PABPN1A171Drub

muscle weakness_Tg(ACTA1-PABPN1*A17)1Drub/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 1, David Rubinsztein
  http://metadb.riken.jp/db/mgi_rdf/MGI:3693297

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(ACTA1-PABPN1*A17)1Drub/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(ACTA1-PABPN1*A17)1Drub

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• muscle weakness
  http://purl.obolibrary.org/obo/MP_0000747

文献

http://purl.org/net/cito/citesAsAuthority

• Janet E. Davies, et.al., Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice., Nature medicine, 2005, 11
  http://rdf.ncbi.nlm.nih.gov/pubmed/15864313